Comparison Of Medicaid And Private Insurance On The Survival Outcomes Of Colorectal Carcinoma

Colorectal carcinoma (CRC) stands as one of the primary contributors to global cancer-related mortalities. Using the NIH’s SEER database, the study evaluated the influence of insurance type - Medicaid and private insurance - on CRC survival among 350,000+ cases. Kaplan-Meier curves depicted survival differences, and Cox Proportional Hazards assessed the insurance-survival relationship, accounting for age, stage, and ethnicity. Findings: median survival was 6.41 years for private insurance holders and $\mathbf{3. 5}$ years for Medicaid beneficiaries. The results indicate that privately insured patients have a higher median survival rate in comparison to those with Medicaid. The research shines light onto the prevailing healthcare disparities in the United States, which are contingent upon economic and insurance status, thus underscoring the imperative need for policy reform.